Health and economic implications of HPV vaccination in the United States.
about
HPV and Cervical Cancer: Updates on an Established RelationshipHuman Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesCost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United StatesHuman papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active womenEurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.Epidemiology and costs of cervical cancer screening and cervical dysplasia in ItalyCost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.Statewide HPV vaccine initiation among adolescent females in North Carolina.Cost-effectiveness of different human papillomavirus vaccines in SingaporePatient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.Need for effective HPV vaccine promotional messaging before sexual activity beginsThe value of improving failures within a cervical cancer screening program: an example from Norway.Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?An updated natural history model of cervical cancer: derivation of model parameters.Anogenital malignancies and pre-malignancies.Impact of genital warts on health related quality of life in men and women in mainland China: a multicenter hospital-based cross-sectional study.Perspective for prophylaxis and treatment of cervical cancer: an immunological approach.Cross-cultural differences and sexual risk behavior of emerging adults.Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types.HPV vaccine acceptance, utilization and expected impacts in the U.S.: Where are we now?Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot studyNutrition economics - characterising the economic and health impact of nutrition.Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patientsTowards the eradication of HPV infection through universal specific vaccination.Predictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US Midwest.Vaccinating women previously exposed to human papillomavirus: a cost-effectiveness analysis of the bivalent vaccine.Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccineCost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unitPrevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparitiesComparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model.Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey.Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran.Next Generation Cancer Protection: The Bivalent HPV Vaccine for FemalesEvaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.HPV Vaccine Awareness, Barriers, Intentions, and Uptake in Latina Women
P2860
Q22305479-E506D0C5-4A75-4FD4-BDEF-0DBE7AC7E8DEQ22306233-18D4AD20-A250-4639-ABF7-BBBDF5264FA2Q24655328-CBF30902-5433-4299-A1BF-EEDEFBE3C053Q26824062-0E0A21B3-170A-45DA-90D7-240527ADEBB7Q30251868-7CCFA0A2-268C-4B45-8D3D-F6F224512CD7Q30658080-87F3714A-FE45-4641-8ABC-A96BDD83E2E6Q33412571-9447BBEB-0A4E-4A60-8185-C55A193361FEQ33523171-7780BD45-615C-4093-8DDB-93C8D40E6EC7Q33600592-AD0A4F32-8E66-4261-9D99-A1E997656592Q33859018-15E8C2F0-8FFD-4F1B-AACE-54614BBC01FBQ33918719-CE8E15B2-0C12-4E62-83C5-EE74BC54B2C6Q33934529-26751BE2-5653-4DCF-825B-19DD0087BCE0Q33962747-206E8417-AD0D-488E-9208-2C9E4E4053A4Q34021105-4F8FC3E0-33A3-41F6-9F8E-B09C6305DB9FQ34029941-0159BD27-9126-4BE8-ACDE-687FFB362959Q34083083-C38A544F-80A9-47CD-9398-033DD15CBAE7Q34161073-16761AC6-EDF3-43A3-B25F-24631B8F31B7Q34180616-B9AB66AC-6ADA-4D08-B047-320D88D3BB7AQ34181909-E7A2B6EA-F6A4-4B9E-92B4-5B0CA1692E27Q34276265-CA69AB30-1F47-4029-A257-12CE4F7B25E2Q34370578-8860534D-5C3C-4271-8A35-4431D39CB447Q34440994-A86DD68D-FB89-4405-B133-C462B4A823EDQ34454168-444080D9-372E-49AD-9E4C-D6DD8EF89A6EQ34501500-91CC8231-EACB-4220-BFCB-49D976E5D723Q34619704-C20D1CFA-9BF9-4418-8624-6E66A6A95D57Q34812959-B446386E-A265-4C6A-AE2A-6433CA737884Q34949073-E37DC566-0875-46F8-9DE8-2211B7109B12Q35005743-5035C3B0-8A81-4C1C-BC5D-963A7DC28D5FQ35018891-08C8D619-6E7F-42D8-8AD5-7BDA46A5E1C7Q35029581-9B32A2C7-F0DB-45EC-9AE3-378EBFFE7D0EQ35126586-DD739547-4330-4EC1-9C6F-225FAC152AD2Q35127307-04DA05FA-0E59-4E68-9FDD-F0F3757FF604Q35221177-83CE3E61-E60A-4C5B-A011-23A1BB33A2C7Q35223397-62DF72F0-849F-4019-8E4F-7B13D5F65A0DQ35235306-EFE68ED5-2E1B-43EB-8D7D-3BC90C8A0C80Q35292968-85A80328-6023-479C-9206-7C3184A2264BQ35484171-D8359914-23D4-49C4-A559-BB5E21A97723Q35550810-ACDD2D4A-6CEB-400B-A5F6-E0CFB9E9DD38Q35564876-29EFC841-7463-4E0F-970B-AFBEF854D0C0Q35666008-2F630E8F-BB37-409D-95E5-26F3DF27EE5C
P2860
Health and economic implications of HPV vaccination in the United States.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Health and economic implications of HPV vaccination in the United States.
@ast
Health and economic implications of HPV vaccination in the United States.
@en
Health and economic implications of HPV vaccination in the United States.
@nl
type
label
Health and economic implications of HPV vaccination in the United States.
@ast
Health and economic implications of HPV vaccination in the United States.
@en
Health and economic implications of HPV vaccination in the United States.
@nl
prefLabel
Health and economic implications of HPV vaccination in the United States.
@ast
Health and economic implications of HPV vaccination in the United States.
@en
Health and economic implications of HPV vaccination in the United States.
@nl
P2860
P356
P1476
Health and economic implications of HPV vaccination in the United States.
@en
P2093
Jane J Kim
P2860
P304
P356
10.1056/NEJMSA0707052
P407
P50
P577
2008-08-01T00:00:00Z